BRCA2 and pancreatic neoplasm: Capan‐1 cells showed significantly higher sensitivity to chlorambucil, as well as to cisplatin and olaparib, when compared to MIA PaCa‐2 pancreatic cancer cells with normal BRCA2 expression (Fig 3A).